Skip to main content
Download PDF

Association between the neutrophil-to-lymphocyte ratio and in-hospital mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit

European Journal of Medical Research volume 29, Article number: 260 (2024) Cite this article

Abstract

Background

The objective of this study was to investigate the correlation between neutrophil-to-lymphocyte ratios (NLR) and the risk of in-hospital death in patients admitted to the intensive care unit (ICU) with both chronic kidney disease (CKD) and coronary artery disease (CAD).

Methods

Data from the MIMIC-IV database, which includes a vast collection of more than 50,000 ICU admissions occurring between 2008 and 2019, was utilized in the study and eICU-CRD was conducted for external verification. The Boruta algorithm was employed for feature selection. Univariable and multivariable logistic regression analyses and multivariate restricted cubic spline regression were employed to scrutinize the association between NLR and in-hospital mortality. The receiver operating characteristic (ROC) curves were conducted to estimate the predictive ability of NLR.

Results

After carefully applying criteria to include and exclude participants, a total of 2254 patients with CKD and CAD were included in the research. The findings showed a median NLR of 7.3 (4.4, 12.1). The outcomes of multivariable logistic regression demonstrated that NLR significantly elevated the risk of in-hospital mortality (OR 2.122, 95% confidence interval [CI] 1.542–2.921, P < 0.001) after accounting for all relevant factors. Further insights from subgroup analyses unveiled that age and Sequential Organ Failure Assessment (SOFA) scores displayed an interactive effect in the correlation between NLR and in-hospital deaths. The NLR combined with traditional cardiovascular risk factors showed relatively great predictive value for in-hospital mortality (AUC 0.750).

Conclusion

The findings of this research indicate that the NLR can be used as an indicator for predicting the likelihood of death during a patient’s stay in the intensive care unit, particularly for individuals with both CAD and CKD. The results indicate that NLR may serve as a valuable tool for assessing and managing risks in this group at high risk. Further investigation is required to authenticate these findings and investigate the mechanisms that underlie the correlation between NLR and mortality in individuals with CAD and CKD.

Introduction

Chronic kidney disease (CKD) has a substantial impact on healthcare systems globally, leading to increased illness and death rates. The occurrence of coronary artery disease (CAD) is much higher in individuals with CKD compared to the overall population, often leading to a negative prognosis [1]. Furthermore, the causes of vascular ailments in individuals with concomitant CAD and CKD are more complicated and involve variables other than atherosclerosis and inflammation [2]. Therefore, it is critical to ascertain whether inflammation and unfavorable outcomes are still associated in this group.

Neutrophil-to-lymphocyte ratios (NLR) have the potential to be innovative biomarkers of the underlying inflammatory process [3]. They may also be excellent predictors in patients with a variety of diseases including immune-related adverse outcomes in cancer patients [4], ischemic stroke [5], cardiovascular disease [6], the progression of end-stage renal disease (ESRD) [7] and hematological disorders [8]. Lately, NLR has also been considered an option for astronaut immunological state monitoring [9]. The inflammatory response is a key mechanism of coronary atherosclerosis in patients with normal renal function. Several prior clinical studies have shown that NLR is linked to cardiovascular disease severity, in-hospital mortality, cardiovascular morbidity, and long-term prognosis in patients with cardiovascular disease [10,11,12,13].

However, the role of inflammation in disease incidence and progression varies from normal kidney function people and CKD patients, especially combined with CAD. Moreover, there was still uncertainty regarding the relationship between these ICU patients’ NLR and unfavorable hospital outcomes. Using information from a publicly accessible database, this research assessed the significance of the NLR in predicting the probability of in-hospital mortality in the intensive care unit for individuals with CKD and CAD.

Methods

Data sources and extraction

The research employed the Medical Information Mart for Intensive Care-IV (MIMIC-IV), an openly accessible repository containing data from more than 50,000 admissions to the intensive care unit (ICU) at Beth Israel Deaconess Medical Center in Boston, Massachusetts, spanning from 2008 to 2019 [14]. The MIMIC-IV dataset covers a vast array of data, comprising demographic details, vital indicators, examination outcomes, and diagnoses, recorded using the ICD-9 and ICD-10 codes of the International Classification of Diseases. Furthermore, the research conducted the Telehealth Intensive Care Unit Collaborative Research Database (eICU-CRD) for external verification, which is a publicly available multicenter database over 200,000 ICU admissions from 208 hospitals. Jingjing Luo, the author, successfully acquired the necessary certification (certification number 12890900) to access the databases and retrieve the essential variables for the study. Since the databases guaranteed the confidentiality of patients, obtaining individual patient consent was considered unnecessary. The research included individuals who were diagnosed with both CAD and CKD using ICD-9 and ICD-10 codes from the website https://www.icd.who.int/browse10/2019/en. CAD was defined according to the codes 410–411 (ICD-9) and I20–I21 (ICD-10), and CKD was defined based on the codes 585, V451 (ICD-9) and N18, Z99.2 (ICD-10) [15]. Individuals who had less than 6 h of ICU stay were under the age of 18, lacked baseline creatinine readings, or had over 30% missing data, or the absence of lymphocyte and neutrophil values, were excluded. In cases of multiple admissions, only data from the initial admission were considered. Using pgAdmin PostgreSQL tools (version 1.22.1), we extracted data from the two databases including demographic data, lab findings, vital signs recorded hourly, existing health conditions, prescribed drugs, surgical operations, details of ICU stay, and records of mortality during hospitalization. The dataset utilized the 'mice' package in R for imputing missing data [16].

Feature selection

After establishing the significance of the study variables, an important step was to select the features to simplify the dataset. The Boruta algorithm, which played a key role in this process (Additional file 1: Materials S1), employed the random forest classifier method, thereby significantly impacting the procedure. The algorithm created shadow features, duplicating the original dataset, and compared the Z-scores between genuine and shadow features in each iteration. Features with a Z-score higher than the maximum Z-score for shadow features were kept, while those below were removed [17].

Afterward, the R package called ‘ingredients’ was employed to calculate various metrics including root mean square error (RMSE) loss following permutations, the percentage rise in mean square error (%IncMSE), and the growth in node purity (IncNodePurity). These metrics were used to evaluate the significance of variables in the random forest model [18]. RMSE and MSE serve as common indicators for evaluating machine learning model performance, with lower values indicating better fit. %IncMSE reflects the percentage increase in MSE when a feature is added, ranging from 0 to positive infinity. A small % of IncMSE implies minimal model performance change, while a larger value suggests a substantial change after feature addition [19]. Node purity measures the classification purity of nodes in the decision tree, indicating the extent to which a feature enhances node purity when added. A higher IncNode Purity value denotes a greater contribution to node classification, resulting in increased node purity [20].

Combining these results with clinical insights and addressing variable collinearity, the most pertinent variables associated with in-hospital mortality were incorporated into the final model.

Statistical analysis

The hospital stay determined the stratification of patients into two groups according to their survival status. Comparisons between categorical variables, expressed as percentages, were conducted using either Fisher’s exact probability method or Chi-square tests. The Wilcoxon rank sum test was used to evaluate the medians of continuous variables, which were represented as interquartile ranges.

The NLR value was determined by dividing the neutrophils (NEU, 109/L) by the lymphocytes (LYM, 109/L), which were the highest absolute values recorded for NEU and LYM throughout the patient's stay in the hospital. Univariable and multivariable logistic regression analyses were conducted to investigate the correlation between NLR and the risk of in-hospital mortality. Model 1 exclusively featured NLR without additional adjustments. Gender and age modifications were integrated into Model 2. Taking into account feature selection results and adjustments made according to clinical expertise, Model 3 was fully fine-tuned. Moreover, a trichotomous multivariable restricted cubic spline (RCS) regression was utilized to investigate possible non-linear associations between NLR and mortality during hospitalization. Age, gender, SOFA score, diabetes, dialysis, and acute coronary syndrome (ACS) were taken into account in subgroup analyses, and interactions were assessed using P values. In addition, receiver operating characteristic (ROC) curves were conducted to compare NLR with traditional cardiovascular scores (age, sex, max systolic blood pressure, treatment for blood pressure, diabetes, body mass index (BMI), dialysis) and area under curves (AUC) were calculated. The Delong’s test was performed to compare different ROC curves.

SPSS (version 26.0, IBM) and R (version 4.1.3, Austria) were utilized for all statistical analyses. A significance level of less than 0.05 was established for statistical significance, using a two-sided P value.

Results

Baseline characteristics

The study included 2254 patients with chronic kidney disease (CKD) and coronary artery disease (CAD) from MIMIC-IV, based on the criteria for inclusion and exclusion (Fig. 1). The median NLR was 7.3 (4.4, 12.1). Out of the total number of patients, 357 individuals (15.8%) passed away during their hospital stay, whereas the remaining 1897 patients managed to survive. The baseline characteristics are summarized in Table 1 and Additional file 2: Table S1. The NLR values and baseline serum creatinine were higher in patients who passed away while receiving hospital care, and they also had increased risks for myocardial infarction (P < 0.001).

Fig. 1
figure 1

The selection flowchart of CKD and CAD patients from the MIMIC-IV database. MIMIC Medical Information Mart for Intensive Care

Full size image
Table 1 Baseline characteristic for patients included in the study divided by in-hospital situation
Full size table

Feature selection

The Boruta algorithm confirmed 77 of 137 variables that were the most related to in-hospital death (Fig. 2, and Additional file 2: Table S2). Additional file 2: Table S3 displays the selection of the top 30 variables deemed most significant based on RMSE loss following permutations, %IncMSE, and IncNodePurity. The final complete adjustment model selected factors based on their Z-scores in the Boruta analysis surpassing the shadow features. Additionally, factors were included if they had the greatest matched effect and importance in the model, as indicated by RMSE loss after permutations, %IncMSE, and IncNodePurity. These criteria are illustrated in Fig. 3 and Additional file 3: Figure S1. Furthermore, factors were considered if they aligned with previous findings and clinical constraints, such as ACS. After eliminating collinearity, the fully adjusted model included a total of 15 variables: NLR, age, gender, sbp_min, spo2_min, ast_max, phosphate_max, wbc_mean, SOFA, glucose_min, bun_min, platelet_mean, pt_min, ptt_mean, and ACS.

Fig. 2
figure 2

The Boruta algorithm conducted the feature selection for the relationship between NLR and in-hospital mortality. The horizontal axis shows the name of each variable, while the vertical axis represents the Z-value of each variable. The box plot depicts the Z-value of each variable in the model calculation, with green boxes representing important variables, yellow representing tentative attributes, and red representing unimportant variables. NLR neutrophil-to-lymphocyte ratio, scr serum creatinine, eGFR estimated glomerular filtration rate, ACS acute coronary syndrome, HT hypertension, max maximum, min minimum, WBC white blood cell, RBC red blood cell, ALT alanine aminotransferase, INR International Normalized Ratio, PT prothrombin time, SOFA sequential organ failure assessment, HR heart rate, SpO2 oxyhemoglobin saturation

Full size image
Fig. 3
figure 3

Top 30 important variables for the relationship between NLR and in-hospital mortality based on the percentage of the increase in mean square error and the increase in node purity. NLR neutrophil-to-lymphocyte ratio, max maximum, min minimum, WBC white blood cell, ALT alanine aminotransferase, PT prothrombin time, SOFA sequential organ failure assessment, SpO2 oxyhemoglobin saturation, %IncMSE the percentage of the increase in mean square error, IncNodePurity the increase in node purity

Full size image

NLR and in-hospital mortality

According to the database, there were 357 in-hospital deaths patients (15.7%). The NLR was found to have a non-linear relationship with in-hospital death risk according to the RCS model. The NLR value for an OR value across 1 is around 7.32(Fig. 4).

Fig. 4
figure 4

The nonlinear association between the NLR and in-hospital mortality after full adjustment via multivariable RCS regression. The cutoff value in the plot of in-hospital death risk was 7.32. NLR, neutrophil-to-lymphocyte ratio; RCS, restricted cubic spline

Full size image

All patients with CKD and CAD were divided into two categories based on the NLR: Q1 (NLR ≤ 7.32), and Q2 (NLR > 7.32). Additional file 2: Table S4 illustrates the univariable and multivariable logistic regression analyses results. After accounting for all influencing factors (Table 2, Model 3), the findings from multivariable logistic regression demonstrated that the NLR raised the risk of in-hospital mortality (OR 2.122, 95% CI 1.542–2.921, P < 0.001). When NLR was used as a continuous variable, it still increased the risk of hospital death (OR 1.027, 95% CI 1.016–1.039, P < 0.001).

Table 2 The association between various NLR groups and in-hospital mortality
Full size table

Subgroup analysis

To validate the correlation between the NLR and in-hospital death, subgroup analyses were performed based on age, gender, SOFA score, and medical conditions such as ACS, diabetes, and dialysis. The interaction between the NLR and in-hospital deaths was influenced by age and SOFA score, whereas gender, diabetes, ACS, and dialysis did not exhibit any interaction with this relationship (Table 3). However, the association between NLR and in-hospital death needed to be further explored (P > 0.05).

Table 3 The subgroup analysis result of multivariable-adjusted OR for association between NLR and hospital mortality
Full size table

NLR and traditional cardiovascular scores

The ROC analysis exhibited that NLR combined with traditional cardiovascular risk factors improved the predictive value for hospital mortality in the CKD and CAD patients in ICU (Fig. 5A). To be specific, the combined model which added NLR to traditional risk factors had a more accurate prediction (AUC 0.750) than traditional risk factors model (AUC 0.708, P < 0.001 by DeLong’s test).

Fig. 5
figure 5

The predictive value of NLR. The combined model (A) which added NLR to traditional risk factors had a more accurate prediction (AUC 0.750) than traditional risk factors model (AUC 0.708, P < 0.001 by DeLong’s test). NLR had good predictive values in the external database (B). AUC, area under curves; NLR, neutrophil-to-lymphocyte ratio

Full size image

External validation

The study included 1119 patients from eICU-CRD, based on the same criteria as training set. The median NLR was 7.29 (4.4, 11.8). 188 individuals (16.8%) passed away during their hospital stay. The baseline characteristics are summarized in Additional file 2: Table S5. NLR had good predictive values in the external database (AUC = 0.725, Fig. 5B).

Discussion

The study provided strong evidence that supports the significance of NLR as a predictive factor for in-hospital death among patients who simultaneously had CAD and CKD in the ICU environment. The findings underscored that, within a specific range, an elevated NLR was indicative of an increased likelihood of in-hospital mortality among individuals with both CKD and CAD. Significantly, even after careful control for possible confounding factors, the connection between NLR and increased mortality during hospitalization remained statistically significant.

The role of inflammation is crucial in starting, advancing, and destabilizing atherosclerotic plaques. There is a strong consensus that systemic inflammation is associated with inflammation in the vascular walls [21]. The activation of lymphocytes and monocytes is crucial in the early phases of atherosclerosis, whereas neutrophils are implicated in plaque destabilization and thrombosis [22]. Importantly, the NLR functions as an easily accessible biomarker that indicates inflammation in the vascular wall [23], and its predictive importance has been recorded in different cardiovascular disorders [24]. Elevated NLR levels have been linked to an augmented risk of atrial arrhythmia [25,26,27], ventricular arrhythmia [28], and adverse outcomes in acute decompensated heart failure [29], acute coronary syndromes [30] and CKD [31], and overall mortality [32] in diverse populations.

CKD represents a persistent inflammatory state, with inflammation being recognized as a crucial catalyst for progressive tubule-interstitial fibrosis, ultimately leading to end-stage renal disease (ESRD) [33]. Numerous investigations have underscored the pivotal role of inflammation in the trajectory of declining kidney function [34]. Notably, anti-inflammatory interventions targeting tubulointerstitial fibrosis in CKD have shown promise in conferring renal protective effects [35]. Extensive research has further elucidated the prognostic value of inflammatory markers in the context of CKD, with studies revealing that an elevation in neutrophil count coupled with a reduction in lymphocyte counts serves as a predictive indicator for mortality in both hemodialysis and peritoneal dialysis patients [36]. Additionally, the NLR has emerged as a valuable metric, reflecting the progression rate from stage 4 chronic kidney disease to the necessity for dialysis [37].

However, there is a paucity of data substantiating the associations between NLR and the mortality risk in individuals afflicted with both CKD and CAD. Based on our current understanding, this research is the first investigation that examines the connection between NLR and in-hospital death in ICU patients who have both CAD and CKD, using a considerable number of participants.

After conducting a multivariate regression analysis and then performing a subgroup analysis, our results confirmed that there is a significant and independent connection between NLR and the likelihood of in-hospital death in patients who have been diagnosed with both CKD and CAD [38]. Alternatively, it was conceivable that the immune system underwent compromise as an integral component of CKD, and NLR served as a surrogate marker for this intricate biological phenomenon.

In our subgroup analysis, it was observed that the non-linear association between NLR and in-hospital mortality among patients with both CAD and CKD in the ICU remained consistent across various subgroups, including elderly individuals, both male and female cohorts, those with and without diabetes, those without acute coronary syndrome (non-ACS), non-dialysis patients, and those with different ranges of Sequential Organ Failure Assessment (SOFA) scores. Furthermore, a significant interaction effect was identified with age and SOFA score (P for interaction < 0.05). Our findings indicated that a heightened NLR in elderly patients with CAD and CKD in the ICU was associated with an increased risk of in-hospital mortality. This observed association may be elucidated by the potential mechanism wherein the aging process contributes to immune system compromise, and the NLR serves as a surrogate marker for this intricate biological phenomenon [32]. The SOFA score, initially termed Sepsis-related Organ Failure Assessment, was introduced by The Working Group on Sepsis-Related Problems in 1996 [39]. This scoring system evaluates the functioning of six organ systems, assigning scores ranging from 0 (indicating no organ dysfunction) to 4 (indicating severe organ dysfunction). The cumulative score, derived by summing individual organ scores, ranges from 0 to 24. Numerous studies have consistently demonstrated its efficacy in predicting mortality among cohorts of critically ill patients [40,41,42,43]. We observed a significant interaction between the SOFA score and the NLR in patients with both CKD and CAD. This interaction was found to be associated with the prognosis of the patients.

Previous studies have indicated that NLR plays a very crucial role in patients with renal insufficiency, especially in the ICU. In patients with acute kidney injury admitted to the ICU, NLR was shown to be an independent predictor of accelerated progression of acute kidney injury and in-hospital mortality. A large cohort study demonstrated a J-shaped association between acute kidney injury progression and NLR [44]. Furthermore, in patients with end-stage renal disease, i.e., hemodialysis status, NLR was significantly associated with higher erythropoietic resistance, whereas platelet lymphocyte ratio was not associated with erythropoietin responsiveness reflected by erythropoietic resistance, which demonstrated the important predictive role of NLR in the clinical setting [45]. Further, a small sample size CKD cohort study showed that higher NLR reflected the advanced stage of CKD, suggesting that NLR could play a role as a biomarker for predicting CKD progression [46]. However, the role of NLR in the CKD combined with CAD population with higher mortality has not been explored.

Our findings bore significant implications for clinical practice and patient care. Within our investigation, an elevated NLR emerged as a discernible factor linked to heightened in-hospital mortality among individuals concurrently diagnosed with CAD and CKD within a defined spectrum. This observation underscored the potential utility of NLR as a pertinent instrument for risk stratification and management within this inherently high-risk patient cohort. To address the augmented risk associated with elevated NLR levels, a comprehensive risk management strategy was warranted. This strategy should have encompassed assertive interventions targeting cardiovascular risk factors, including meticulous control of lipid levels, blood pressure regulation, and support for smoking cessation. Regular monitoring coupled with timely interventions in cases of elevated NLR levels assumed pivotal significance in mitigating the incidence of adverse outcomes.

The present investigation marked the inaugural exploration into the role of the NLR in patients simultaneously afflicted with CKD and CAD within the ICU setting. This study underscored the imperative for a comprehensive risk management strategy in individuals grappling with the dual burden of CAD and CKD, with the NLR emerging as a pivotal instrument in this paradigm. Nevertheless, it is essential to acknowledge the limitations inherent in our findings, which are influenced by several factors. First, the study is primarily constrained by a modest sample size. It is imperative for future research endeavors to prioritize larger sample sizes, thereby enhancing the robustness of evidence needed to substantiate our findings. Second, the retrospective nature of this study is notable, prompting considerations regarding the potential impact of confounding variables and selection bias on the observed outcomes. Moreover, the highest absolute NEU and LYM could originate from different blood tests. The NLR value in this study were calculated based on the highest absolute NEU and LYM values recorded throughout the patient’s stay in the hospital. The NEU count will necessarily increase and LYM count will decrease in a patient with worsening clinic generally. Therefore, it impractical to obtain both the highest NEU and LYM values in the same tube of blood sample. The relationship between the NLR ratio at admission and prognosis needs to be further explored, limited by the natural shortcomings of public databases. Further, it is essential to acknowledge that the dataset employed in this study may lack crucial clinical details, including the patient’s dialysis status, which could potentially influence inflammatory status. To address these constraints, upcoming research endeavors should strive to encompass a comprehensive spectrum of clinical information and systematically monitor the longitudinal fluctuations in NLR values.

Conclusions

As a result, our research showcased the prognostic significance of NLR in predicting the likelihood of in-hospital death among ICU patients suffering from both CAD and CKD. In this high-risk cohort, NLR emerged as a potentially valuable instrument for risk stratification and subsequent management. Further research is necessary to confirm these results and clarify the underlying mechanisms that govern the link between NLR and mortality in individuals with both CAD and CKD.

Availability of data and materials

The data supporting this study’s findings are available from the Medical Information Mart for Intensive Care IV (MIMIC IV), but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are, however, available from the author Jingjing Luo (luojingjing677@foxmail.com) upon reasonable request and with permission of MIMIC.

Abbreviations

NLR:

Neutrophil-to-lymphocyte ratio

CKD:

Chronic kidney disease

CAD:

Coronary artery disease

MIMIC-IV:

Medical Information Mart for Intensive Care IV

LR:

Logistic regression

ESRD:

End stage renal disease

ML:

Machine learning

ICD-9:

International Classification of Diseases and Ninth Revision

ICD-10:

International Classification of Diseases and tenth Revision

ICU:

Intensive care unit

scr:

Serum creatinine

eGFR:

Estimated glomerular filtration rate

ACS:

Acute coronary syndrome

HT:

Hypertension

PCI:

Percutaneous coronary intervention

CABG:

Coronary artery bypass grafting

NOAC:

Non-vitamin K antagonist oral anticoagulant

CRRT:

Continuous renal replacement therapy

max:

Maximum

min:

Minimum

WBC:

White blood cell

RBC:

Red blood cell

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

ALP:

Alkaline phosphatase

BUN:

Blood urea nitrogen

INR:

International normalized ratio

PT:

Prothrombin time

PTT:

Partial thromboplastin time

SOFA:

Sequential organ failure assessment

sbp:

Systolic blood pressure

dbp:

Diastolic blood pressure

mbp:

Mean blood pressure

HR:

Heart rate

SpO2 :

Oxyhemoglobin saturation

RMSE:

Root mean square error

%IncMSE:

The percentage of the increase in mean square error

IncNodePurity:

The increase in node purity

NEU:

Neutrophils

LYM:

Lymphocytes

ROC:

Receiver operating characteristic

AUC:

Area under curves

BMI:

Body mass index

eICU-CRD:

The Telehealth Intensive Care Unit Collaborative Research Database

References

  1. Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, et al. Chronic kidney disease and coronary artery disease: JACC State-of-the-Art review. J Am Coll Cardiol. 2019;74(14):1823–38.

    Article  CAS  PubMed  Google Scholar 

  2. Yun HR, Joo YS, Kim HW, Park JT, Chang TI, Son NH, et al. Coronary artery calcification score and the progression of chronic kidney disease. J Am Soc Nephrol. 2022;33(8):1590–601.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocana A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124.

    Article  PubMed  Google Scholar 

  4. Zhang W, Tan Y, Li Y, Liu J. Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Front Immunol. 2023;14:1234142.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Gong P, Liu Y, Gong Y, Chen G, Zhang X, Wang S, et al. The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke. J Neuroinflamm. 2021;18(1):51.

    Article  CAS  Google Scholar 

  6. Trtica Majnaric L, Guljas S, Bosnic Z, Seric V, Wittlinger T. Neutrophil-to-lymphocyte ratio as a cardiovascular risk marker may be less efficient in women than in men. Biomolecules. 2021;11(4):528.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Yuan Q, Wang J, Peng Z, Zhou Q, Xiao X, Xie Y, et al. Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE). J Transl Med. 2019;17(1):86.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Liu J, Zhang S, Mi R, Chen L, Yin Q. Prognostic significance of the neutrophil-to-lymphocyte ratio in peripheral T-cell lymphoma: a meta-analysis. Cancer Cell Int. 2021;21(1):688.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Paul AM, Mhatre SD, Cekanaviciute E, Schreurs AS, Tahimic CGT, Globus RK, et al. Neutrophil-to-lymphocyte ratio: a biomarker to monitor the immune status of astronauts. Front Immunol. 2020;11: 564950.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Li H, Lu X, Xiong R, Wang S. High neutrophil-to-lymphocyte ratio predicts cardiovascular mortality in chronic hemodialysis patients. Mediators Inflamm. 2017;2017:9327136.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lin G, Dai C, Xu K, Wu M. Predictive value of neutrophil to lymphocyte ratio and red cell distribution width on death for ST segment elevation myocardial infarction. Sci Rep. 2021;11(1):11506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Garcia-Escobar A, Vera-Vera S, Tebar-Marquez D, Rivero-Santana B, Jurado-Roman A, Jimenez-Valero S, et al. Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: new insights for a potential predictor of anti-cytokine therapy responsiveness. Microvasc Res. 2023;150: 104598.

    Article  CAS  PubMed  Google Scholar 

  13. Bagyura Z, Kiss L, Lux A, Csobay-Novak C, Jermendy AL, Polgar L, et al. Neutrophil-to-lymphocyte ratio is an independent risk factor for coronary artery disease in central obesity. Int J Mol Sci. 2023;24(8):7397.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Johnson A, Bulgarelli L, Pollard T, Horng S, Celi LA, Mark R. Mimic-iv. PhysioNet; 2020. https://physionet.org/content/mimiciv/10/ Accessed 23 Aug 2021.

  15. Ye Z, An S, Gao Y, Xie E, Zhao X, Guo Z, et al. Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit. Cardiovasc Diabetol. 2023;22(1):110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Blazek K, van Zwieten A, Saglimbene V, Teixeira-Pinto A. A practical guide to multiple imputation of missing data in nephrology. Kidney Int. 2021;99(1):68–74.

    Article  PubMed  Google Scholar 

  17. Degenhardt F, Seifert S, Szymczak S. Evaluation of variable selection methods for random forests and omics data sets. Brief Bioinform. 2019;20(2):492–503.

    Article  PubMed  Google Scholar 

  18. Singh NK, Yadav M, Singh V, Padhiyar H, Kumar V, Bhatia SK, et al. Artificial intelligence and machine learning-based monitoring and design of biological wastewater treatment systems. Bioresour Technol. 2023;369: 128486.

    Article  CAS  PubMed  Google Scholar 

  19. Pfau M, von der Emde L, Dysli C, Moller PT, Thiele S, Lindner M, et al. Determinants of cone and rod functions in geographic atrophy: AI-based structure-function correlation. Am J Ophthalmol. 2020;217:162–73.

    Article  PubMed  Google Scholar 

  20. Alvarez-Cabria M, Gonzalez-Ferreras AM, Penas FJ, Barquin J. Modelling macroinvertebrate and fish biotic indices: From reaches to entire river networks. Sci Total Environ. 2017;577:308–18.

    Article  CAS  PubMed  Google Scholar 

  21. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Yayan J. Emerging families of biomarkers for coronary artery disease: inflammatory mediators. Vasc Health Risk Manag. 2013;9:435–56.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Gary T, Pichler M, Belaj K, Hafner F, Gerger A, Froehlich H, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS ONE. 2013;8(7): e67688.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Afari ME, Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev Cardiovasc Ther. 2016;14(5):573–7.

    Article  CAS  PubMed  Google Scholar 

  25. Canpolat U, Aytemir K, Yorgun H, Sahiner L, Kaya EB, Kabakci G, et al. Role of preablation neutrophil/lymphocyte ratio on outcomes of cryoballoon-based atrial fibrillation ablation. Am J Cardiol. 2013;112(4):513–9.

    Article  PubMed  Google Scholar 

  26. Im SI, Shin SY, Na JO, Kim YH, Choi CU, Kim SH, et al. Usefulness of neutrophil/lymphocyte ratio in predicting early recurrence after radiofrequency catheter ablation in patients with atrial fibrillation. Int J Cardiol. 2013;168(4):4398–400.

    Article  PubMed  Google Scholar 

  27. Aribas A, Akilli H, Gul EE, Kayrak M, Demir K, Duman C, et al. Can neutrophil/lymphocyte ratio predict recurrence of non-valvular atrial fibrillation after cardioversion? Anadolu Kardiyol Derg. 2013;13(2):123–30.

    CAS  PubMed  Google Scholar 

  28. Chatterjee S, Chandra P, Guha G, Kalra V, Chakraborty A, Frankel R, et al. Pre-procedural elevated white blood cell count and neutrophil-lymphocyte (N/L) ratio are predictors of ventricular arrhythmias during percutaneous coronary intervention. Cardiovasc Hematol Disord Drug Targets. 2011;11(2):58–60.

    Article  CAS  PubMed  Google Scholar 

  29. Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol. 2011;107(3):433–8.

    Article  PubMed  Google Scholar 

  30. Guasti L, Dentali F, Castiglioni L, Maroni L, Marino F, Squizzato A, et al. Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. A systematic review on more than 34,000 subjects. Thromb Haemost. 2011;106(4):591–9.

    Article  CAS  PubMed  Google Scholar 

  31. Brito GMC, Fontenele AMM, Carneiro E, Nogueira IAL, Cavalcante TB, Vale AAM, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in nondialysis chronic kidney patients. Int J Inflam. 2021;2021:6678960.

    PubMed  PubMed Central  Google Scholar 

  32. Fest J, Ruiter TR, Groot Koerkamp B, Rizopoulos D, Ikram MA, van Eijck CHJ, et al. The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: the Rotterdam Study. Eur J Epidemiol. 2019;34(5):463–70.

    Article  CAS  PubMed  Google Scholar 

  33. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol. 2011;7(12):684–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol. 2013;3(2):957–76.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Liu C, Mei W, Tang J, Yuan Q, Huang L, Lu M, et al. Mefunidone attenuates tubulointerstitial fibrosis in a rat model of unilateral ureteral obstruction. PLoS ONE. 2015;10(6): e0129283.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Reddan DN, Klassen PS, Szczech LA, Coladonato JA, O’Shea S, Owen WF Jr, et al. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant. 2003;18(6):1167–73.

    Article  CAS  PubMed  Google Scholar 

  37. Kocyigit I, Eroglu E, Unal A, Sipahioglu MH, Tokgoz B, Oymak O, et al. Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease. J Nephrol. 2013;26(2):358–65.

    Article  CAS  PubMed  Google Scholar 

  38. Carbone F, Nencioni A, Mach F, Vuilleumier N, Montecucco F. Pathophysiological role of neutrophils in acute myocardial infarction. Thromb Haemost. 2013;110(3):501–14.

    Article  CAS  PubMed  Google Scholar 

  39. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–10.

    Article  CAS  PubMed  Google Scholar 

  40. Peres Bota D, Melot C, Lopes Ferreira F, Nguyen Ba V, Vincent JL. The multiple organ dysfunction score (MODS) versus the sequential organ failure assessment (SOFA) score in outcome prediction. Intensive Care Med. 2002;28(11):1619–24.

    Article  PubMed  Google Scholar 

  41. Innocenti F, Tozzi C, Donnini C, De Villa E, Conti A, Zanobetti M, et al. SOFA score in septic patients: incremental prognostic value over age, comorbidities, and parameters of sepsis severity. Intern Emerg Med. 2018;13(3):405–12.

    PubMed  Google Scholar 

  42. Karakike E, Kyriazopoulou E, Tsangaris I, Routsi C, Vincent JL, Giamarellos-Bourboulis EJ. The early change of SOFA score as a prognostic marker of 28-day sepsis mortality: analysis through a derivation and a validation cohort. Crit Care. 2019;23(1):387.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Jentzer JC, Bennett C, Wiley BM, Murphree DH, Keegan MT, Barsness GW. Predictive value of individual Sequential Organ Failure Assessment sub-scores for mortality in the cardiac intensive care unit. PLoS ONE. 2019;14(5): e0216177.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Chen JJ, Kuo G, Fan PC, Lee TH, Yen CL, Lee CC, et al. Neutrophil-to-lymphocyte ratio is a marker for acute kidney injury progression and mortality in critically ill populations: a population-based, multi-institutional study. J Nephrol. 2022;35(3):911–20.

    Article  CAS  PubMed  Google Scholar 

  45. Zhang J, Lu X, Wang S, Li H. Neutrophil-to-lymphocyte ratio and erythropoietin resistance among maintenance hemodialysis patients. Blood Purif. 2022;51(8):708–13.

    Article  CAS  PubMed  Google Scholar 

  46. Kim J, Song SH, Oh TR, Suh SH, Choi HS, Kim CS, et al. Prognostic role of the neutrophil-to-lymphocyte ratio in patients with chronic kidney disease. Korean J Intern Med. 2023;38(5):725–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We acknowledge all participants in the MIMC IV research team for survey design and data collection.

Funding

This work was supported by the National Natural Science Foundation of China (82241217, 82170504, and 81730015).

Author information

Authors and Affiliations

  1. Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Jingjing Luo, Yufan Zhou, Yu Song, Xinling Du & Jiahong Xia

  2. Department of Cardiovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Henan Province, 450052, China

    Dashuai Wang

  3. Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100038, China

    Meihong Li & Jihong Kang

  4. Department of Cardiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China

    Ping Ye

Authors
  1. Jingjing Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yufan Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dashuai Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Meihong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xinling Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jihong Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ping Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jiahong Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JL and YZ contributed to the study design. JL, YZ, YS, and DW contributed to data collection, manuscript writing, data processing, and figure mapping. JL, YZ, and YS contributed to data proofreading. DW and JL contributed to formal analysis; and writing—original draft preparation; XD, JK, PY, and JX contributed to review and editing. All authors have read and agreed to the published version of the manuscript.

Corresponding authors

Correspondence to Xinling Du, Jihong Kang, Ping Ye or Jiahong Xia.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Materials S1.

R code for feature selection.

Additional file 2: Table S1.

Baseline characteristics for patients included in the study divided by in-hospital survival status. (Full version). Table S2. Feature selection for the relationship between various NLR indices and in-hospital mortality analyzed by the Boruta algorithm. Table S3. Top 30 important variables for the relationship between NLR and in-hospital mortality according to three methods. Table S4. The univariable and multivariable for all identified covariates as risk factor for in-hospital mortality. Table S5. Baseline characteristics for external validation.

Additional file 3: Figure S1.

Feature selection for the relationship between NLR and in-hospital mortality based on root mean square error (RMSE) loss after permutations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, J., Zhou, Y., Song, Y. et al. Association between the neutrophil-to-lymphocyte ratio and in-hospital mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit. Eur J Med Res 29, 260 (2024). https://doi.org/10.1186/s40001-024-01850-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40001-024-01850-3

Keywords

European Journal of Medical Research

ISSN: 2047-783X

Contact us